Development of a high-throughput screening platform to identify new therapeutic agents for Medulloblastoma Group 3Inés Fallon(System Biosciences (United States)), Eva Méndez(Fundación Oncohematología Infantil)SLAS DISCOVERYFebruary 12, 202410.1016/j.slasd.2024.100147Cited by 4SaveCiteExport RISWatch citationsRelated Papers“PBT-SCREEN”, a high-throughput screening platform to identify new therapeutic agents for Medulloblastoma Group 3|Research Square|2023|0